rs2255632

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001365999.1(SZT2):​c.8626-3T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.385 in 1,613,750 control chromosomes in the GnomAD database, including 126,714 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 9089 hom., cov: 32)
Exomes 𝑓: 0.39 ( 117625 hom. )

Consequence

SZT2
NM_001365999.1 splice_region, intron

Scores

2
Splicing: ADA: 0.00003135
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.92

Publications

25 publications found
Variant links:
Genes affected
SZT2 (HGNC:29040): (SZT2 subunit of KICSTOR complex) The protein encoded by this gene is expressed in the brain, predominantly in the parietal and frontal cortex as well as in dorsal root ganglia. It is localized to the peroxisome, and is implicated in resistance to oxidative stress. It likely functions by increasing superoxide dismutase (SOD) activity, but itself has no direct SOD activity. Studies in mice show that this gene confers low seizure threshold, and may also enhance epileptogenesis. [provided by RefSeq, Jun 2011]
SZT2 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BP6
Variant 1-43443594-T-C is Benign according to our data. Variant chr1-43443594-T-C is described in ClinVar as Benign. ClinVar VariationId is 260626.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.41 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SZT2NM_001365999.1 linkc.8626-3T>C splice_region_variant, intron_variant Intron 61 of 71 ENST00000634258.3 NP_001352928.1
SZT2NM_015284.4 linkc.8455-3T>C splice_region_variant, intron_variant Intron 60 of 70 NP_056099.3 Q5T011-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SZT2ENST00000634258.3 linkc.8626-3T>C splice_region_variant, intron_variant Intron 61 of 71 5 NM_001365999.1 ENSP00000489255.1 Q5T011-1

Frequencies

GnomAD3 genomes
AF:
0.322
AC:
48915
AN:
151952
Hom.:
9090
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.147
Gnomad AMI
AF:
0.480
Gnomad AMR
AF:
0.392
Gnomad ASJ
AF:
0.465
Gnomad EAS
AF:
0.124
Gnomad SAS
AF:
0.158
Gnomad FIN
AF:
0.407
Gnomad MID
AF:
0.456
Gnomad NFE
AF:
0.414
Gnomad OTH
AF:
0.382
GnomAD2 exomes
AF:
0.337
AC:
84632
AN:
251052
AF XY:
0.337
show subpopulations
Gnomad AFR exome
AF:
0.139
Gnomad AMR exome
AF:
0.330
Gnomad ASJ exome
AF:
0.471
Gnomad EAS exome
AF:
0.112
Gnomad FIN exome
AF:
0.411
Gnomad NFE exome
AF:
0.422
Gnomad OTH exome
AF:
0.381
GnomAD4 exome
AF:
0.391
AC:
571782
AN:
1461680
Hom.:
117625
Cov.:
61
AF XY:
0.386
AC XY:
280696
AN XY:
727152
show subpopulations
African (AFR)
AF:
0.135
AC:
4526
AN:
33480
American (AMR)
AF:
0.340
AC:
15215
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.468
AC:
12242
AN:
26136
East Asian (EAS)
AF:
0.158
AC:
6290
AN:
39700
South Asian (SAS)
AF:
0.169
AC:
14605
AN:
86258
European-Finnish (FIN)
AF:
0.404
AC:
21514
AN:
53274
Middle Eastern (MID)
AF:
0.423
AC:
2438
AN:
5768
European-Non Finnish (NFE)
AF:
0.425
AC:
472556
AN:
1111956
Other (OTH)
AF:
0.371
AC:
22396
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
21027
42054
63082
84109
105136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14158
28316
42474
56632
70790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.322
AC:
48927
AN:
152070
Hom.:
9089
Cov.:
32
AF XY:
0.319
AC XY:
23706
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.147
AC:
6087
AN:
41498
American (AMR)
AF:
0.392
AC:
5990
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.465
AC:
1616
AN:
3472
East Asian (EAS)
AF:
0.123
AC:
637
AN:
5162
South Asian (SAS)
AF:
0.159
AC:
767
AN:
4820
European-Finnish (FIN)
AF:
0.407
AC:
4307
AN:
10576
Middle Eastern (MID)
AF:
0.463
AC:
136
AN:
294
European-Non Finnish (NFE)
AF:
0.414
AC:
28149
AN:
67934
Other (OTH)
AF:
0.380
AC:
802
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1662
3324
4985
6647
8309
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
476
952
1428
1904
2380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.381
Hom.:
23154
Bravo
AF:
0.317
Asia WGS
AF:
0.148
AC:
517
AN:
3478
EpiCase
AF:
0.426
EpiControl
AF:
0.430

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 18, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 18 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jan 08, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
13
DANN
Benign
0.57
PhyloP100
1.9
Mutation Taster
=68/32
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000031
dbscSNV1_RF
Benign
0.0060
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2255632; hg19: chr1-43909265; COSMIC: COSV65167141; COSMIC: COSV65167141; API